Business Description
Spyre Therapeutics is a clinical-stage biotech company based in Waltham, Massachusetts, focused on creating new treatments for inflammatory bowel disease and rheumatic conditions. The company is advancing several drug candidates that target specific proteins involved in inflammation, including standalone antibodies and combination therapies designed to address conditions such as ulcerative colitis and Crohn's disease. Formerly known as Aeglea BioTherapeutics, the company adopted its current name in November 2023 and has been operating since its founding in 2013.
